Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olivia El Naggar"'
Publikováno v:
Medical Sciences, Vol 10, Iss 2, p 28 (2022)
Ovarian cancer accounts for 3% of the total cancers in women, yet it is the fifth leading cause of cancer deaths among women. The BRCA1/2 germline and somatic mutations confer a deficiency of the homologous recombination (HR) repair pathway. Inhibito
Externí odkaz:
https://doaj.org/article/7e8b05338b71490ebf2f49c96df69c50
Autor:
Gabriele Romano, Francesca Paradiso, Peng Li, Pooja Shukla, Lindsay N. Barger, Olivia El Naggar, John P. Miller, Roger J. Liang, Timothy L. Helms, Alexander J. Lazar, Jennifer A. Wargo, Francesca Taraballi, James C. Costello, Lawrence N. Kwong
Publikováno v:
Cancer Immunology Research. 11:558-569
Patients with BRAF-mutant melanoma show significant responses to combined BRAF and MEK inhibition, but most relapse within 2 years. A major reservoir for drug resistance is minimal residual disease (MRD), comprised of drug-tolerant tumor cells laying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40f2da886564af721e6bfcc62c6c6d4
https://doi.org/10.1158/2326-6066.cir-22-0224
https://doi.org/10.1158/2326-6066.cir-22-0224
Supplementary Tables from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
Autor:
Lawrence N. Kwong, James C. Costello, Francesca Taraballi, Jennifer A. Wargo, Alexander J. Lazar, Timothy L. Helms, Roger J. Liang, John P. Miller, Olivia El Naggar, Lindsay N. Barger, Pooja Shukla, Peng Li, Francesca Paradiso, Gabriele Romano
Supplementary Tables S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a524dd6284dda5a6e2b38e7c181e49
https://doi.org/10.1158/2326-6066.22736965
https://doi.org/10.1158/2326-6066.22736965
Autor:
Lawrence N. Kwong, James C. Costello, Francesca Taraballi, Jennifer A. Wargo, Alexander J. Lazar, Timothy L. Helms, Roger J. Liang, John P. Miller, Olivia El Naggar, Lindsay N. Barger, Pooja Shukla, Peng Li, Francesca Paradiso, Gabriele Romano
Supplementary Figures S1-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150d47f956ceb797ad53d571e97f7de3
https://doi.org/10.1158/2326-6066.22736971.v1
https://doi.org/10.1158/2326-6066.22736971.v1
Autor:
Lawrence N. Kwong, James C. Costello, Francesca Taraballi, Jennifer A. Wargo, Alexander J. Lazar, Timothy L. Helms, Roger J. Liang, John P. Miller, Olivia El Naggar, Lindsay N. Barger, Pooja Shukla, Peng Li, Francesca Paradiso, Gabriele Romano
Patients with BRAF-mutant melanoma show substantial responses to combined BRAF and MEK inhibition, but most relapse within 2 years. A major reservoir for drug resistance is minimal residual disease (MRD), comprised of drug-tolerant tumor cells laying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99adcc7a1ff884896453f038fd8e46c5
https://doi.org/10.1158/2326-6066.c.6627970
https://doi.org/10.1158/2326-6066.c.6627970
Autor:
Erin Fahey, Eric T. Alexander, Susan K. Gilmour, Otto Phanstiel, Julia Donnelly, Katelyn Wolfgang, Olivia El Naggar, Kelsey Mariner
Publikováno v:
Cancer Biol Ther
BRAF mutations are present in over half of all melanoma tumors. Although BRAF inhibitors significantly improve survival of patients with metastatic melanoma, recurrences occur within several months. We previously reported that BRAF mutant melanoma ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c89fe34d9d738739ec521874e00a5ad
https://doi.org/10.1080/15384047.2021.1883185
https://doi.org/10.1080/15384047.2021.1883185
Long non-coding RNAs (lncRNAs) regulate diverse cellular processes and are associated with many age-associated diseases. However, the function of lncRNAs in cellular senescence remains largely unknown. Here we characterize the role of lncRNA H19 in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72b181fb7dfa413dfde29f7af153138c
https://doi.org/10.1101/2022.07.07.499142
https://doi.org/10.1101/2022.07.07.499142